#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmogenic right ventricular dysplasia Vulval cancer Li-Fraumeni syndrome Hyperadrenocorticism Congenital generalised lipodystrophy X-linked lymphoproliferative syndrome Hereditary optic atrophy Meningococcal immunisation Lip and/or oral cavity cancer Squamous cell carcinoma of the hypopharynx Non-renal cell carcinoma of kidney Hypochondroplasia Retinitis pigmentosa SAPHO syndrome Oesophageal squamous cell carcinoma stage III More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Life with Disease Progressive multifocal leukoencephalopathy – Diagnostics Fragile X syndrome – Life with Disease Niemann-Pick disease – Basic Information Turner’s syndrome – Basic Information Primary biliary cholangitis – Basic Information Retinitis pigmentosa Idiopathic inflammatory myopathy – Trials in Disease Adrenogenital syndrome – Treatment Short-bowel syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Kd050 Linrodostat Mesilate Quinapril Hydrochloride ICEF15 Cloxacillin Sodium Trientine Dihydrochloride Folinic Acid Follitropin Beta Vilanterol Fasudil Hydrochloride Ngm707 Giroctocogene Fitelparvovec Methoxsalen HUMAN PLASMA Bortezomib SAR443820 Idarubicin Sparsentan Gozetotide Alf-18 Lsta1 More therapies…

    Learn about Your Condition

    Diabetic retinopathy SAPHO syndrome Bladder cancer recurrent Breast proliferative changes Renal cell carcinoma stage IV Breast conserving surgery Pancreaticoduodenectomy Endocrine disorder White matter lesion Bipolar I disorder Monkeypox Cystic fibrosis HER2 negative breast cancer Peritoneal dialysis Corneal dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Study on WT1 mRNA DC Vaccine to Prevent Relapse in Adults with Acute Myeloid Leukemia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Wt1 Mrna Dc
    Belgium

  • Study of WT1 LAMP mRNA DC Immunotherapy for Children with High-Grade Glioma and Diffuse Intrinsic Pontine Glioma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Glioma
    • Brain stem glioma
    Investigated Drugs:
    • Wt1 Lamp Mrna Dc
    Belgium

  • Study on WT1/IL15/IL15Ra mRNA DC Vaccine for Patients with Advanced or Refractory Solid Tumors of the Pancreas, Esophagus, Liver, or Ovaries

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Wt1/Il15/Il15Ra Mrna Dc
    Belgium

  • Study of WT1 LAMP mRNA DC Vaccine for Patients with Malignant Pleural Mesothelioma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pleural mesothelioma malignant
    Investigated Drugs:
    • Wt1 Lamp Mrna Dc
    Belgium

  • Study on WT1 LAMP mRNA DC and Temozolomide for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Wt1 Lamp Mrna Dc
    Belgium

  • Comparison of preservative-free versus preserved dexamethasone and diclofenac eye drops in patients after cataract surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Diclofenac Sodium
    • Dexamethasone
    Belgium
Previous Page
1 … 19 20 21 22 23 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!